SCAI and ovarian carcinoma: It has also been shown that circ_CDR1as enhances the proliferation, migration, and invasion of hepatocellular carcinoma (HCC) via the miR-944/NOX4 pathway38, and as above described, to inhibit cisplatin resistance in ovarian cancer via the miR-1270/SCAI pathway.